Events

Recall of Olympus IgM

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by OLYMPUS France.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2004-09-02
  • Event Country
    France
  • Event Source
    ANSM
  • Event Source URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/retrait-d-un-lot-du-dmdiv-olympus-igm-de-par-la-societe-olympus
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    On August 31, 2004, Olympus France withdrew from the market lot 1275 (per 01.04.05) of the in vitro diagnostic medical device called Olympus IgM - reference OSR6146 following the detection of a poor detection of the phenomenon of This device is intended for the determination of immunoglobulin M (IgM) in human serum and plasma on Olympus analyzers.

Device

Olympus IgM
  • Model / Serial
  • Product Description
    in-vitro_medical_device
  • Manufacturer
    OLYMPUS France

Manufacturer

OLYMPUS France